Efficacy of Intermediate-Dose Cytarabine Induction Regimen in Adult AML
Clinical trial NCT03021330 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03021330
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-08
- Primary completion
- 2026-05-15
- Enrollment
- 1100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.